header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

CALCANEOCUBOID JOINT INVOLVEMENT IN CALCANEAL FRACTURES



Abstract

Background: The reported incidence of calcaneocuboid joint (CCJ) involvement in calcaneal fractures varies considerably. It is largely unknown to what extend CCJ involvement accounts for outcome in these fractures. Therefore, the goal of this study was to analyse the incidence and effects of CCJ involvement in calcaneal fractures.

Patients and Methods: The clinical records of 106 patients, treated between 2001–2007, were reviewed for fracture classification, injury mechanism, surgical treatment and complications. In a prospective cross-sectional study 44 patients were assessed clinically (SF-36 score, AOFAS) and radiographically. Gait analysis was performed using dynamic pedography.

Results: 68 % of all fractures had involvement of the CCJ. Fractures with CCJ involvement were caused by a more severe injury than fractures without CCJ involvement (Mann-Whitney-Test, p=0.03), this is reflected by a strong association between CCJ involvement and fracture classification (Spearman, p< 0.006). Patients with involvement of the CCJ – especially those with a postoperative step in the CCJ – achieved a lower SF-36 score as well as a lower AOFAS score than patients without CCJ involvement. CCJ involvement was associated with more difficulties in walking on rough surface (Spearman, p = 0,020). Limitations during gait were confirmed by dynamic pedography. Grading of posttraumatic OA was associated with fracture classification. (χ2-test p< 0.02) and quality of reduction (χ2-test p< 0.01).

Conclusions: These results indicate that calcaneal fractures with involvement of the calcaneocuboid joint are associated with more severe trauma and worse outcome. Thus the CCJ should be given more credit during surgery and in our research efforts.

Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Tel: +41 44 448 44 00; Email: office@efort.org

Author: Bernd Kinner, Germany

E-mail: bernd.kinner@klinik.uni-r.de